With up to 2.4 million U.S. cases and over 250 million chronic cases globally, hepatitis B infection persists despite the availability of a vaccine. Vaccines work by immunizing the body against a virus to prevent infection; however, there is no cure for individuals who do become infected (for example, at birth). Hepatitis B infection can lead to liver damage and even cancer, posing a threat to public health.
Click here for original story, Scientists simulate step in hepatitis B viral infection to help develop therapies targeted at capsid disassembly
Source: Phys.org